Targeting ferroptosis in hepatocellular carcinoma

被引:14
|
作者
Mo, Yuqian [1 ]
Zou, Zhilin [2 ]
Chen, Erbao [3 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Zhanjiang 524023, Guangdong, Peoples R China
[2] Wenzhou Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen 518036, Guangdong, Peoples R China
关键词
Ferroptosis; Hepatocellular carcinoma; Immunotherapy; Immune microenvironment; SUPPRESSOR-CELLS; LIPID-PEROXIDATION; T-CELLS; 1ST-LINE TREATMENT; CANCER; DYSFUNCTION; SORAFENIB; ZIP14; TRANSPORTER; SENSITIVITY;
D O I
10.1007/s12072-023-10593-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [21] Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
    Zhu, Xinyue
    Sha, Xudong
    Zang, Yan
    Ren, Qiaohui
    Zhang, Shubing
    Ma, Dongyue
    Wang, Lianzi
    Yao, Junxiao
    Zhou, Xinyi
    Yu, Li
    Li, Tao
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (09): : 3621 - 3637
  • [22] Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
    Liu, Beibei
    Liu, Ling
    Liu, Yang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells
    Xinru Jiang
    Hongdan Li
    Yang Liu
    Discover Oncology, 15
  • [24] Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
    Li, Yue
    Zhang, Jiongshan
    Zhang, Kun
    Chen, Yan
    Wang, Wei
    Chen, Hongjie
    Zou, Zengcheng
    Li, Yongwei
    Dai, Min
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
    Wen, Kai
    Yan, Yongcong
    Shi, Juanyi
    Hu, Lei
    Wang, Weidong
    Liao, Hao
    Li, Huoming
    Zhu, Yue
    Mao, Kai
    Xiao, Zhiyu
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [26] Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
    Bekric, Dino
    Ocker, Matthias
    Mayr, Christian
    Stintzing, Sebastian
    Ritter, Markus
    Kiesslich, Tobias
    Neureiter, Daniel
    CANCERS, 2022, 14 (07)
  • [27] Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
    Liu, Yang
    Zhang, Xi
    Zhang, Junjun
    Tan, Juan
    Li, Jie
    Song, Zewen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [28] Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells
    Jiang, Xinru
    Li, Hongdan
    Liu, Yang
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [29] Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression
    Fei, Zuo
    Lijuan, Yin
    Jing, Zhuang
    Xi, Yang
    Yuefen, Pan
    Shuwen, Han
    HUMAN CELL, 2021, 34 (01) : 177 - 186
  • [30] The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
    Zhao, Siqi
    Zheng, Wubin
    Yu, Chao
    Xu, Gaoxin
    Zhang, Xinyi
    Pan, Chao
    Feng, Yongheng
    Yang, Kunxing
    Zhou, Jin
    Ma, Yong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10